Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories

Share:

 
 

Dr. Lalan Wilfong: Practice-Wide Changes at Texas Oncology

July 28, 2020

In recent conversations with the Journal of Clinical Pathways, Lalan Wilfong, M.D., vice president of quality programs and value-based care, emphasized Texas Oncology’s mission to provide high-quality cancer care in a safe environment.

According to Dr. Wilfong, open and ongoing communication with Texas Oncology’s staff and patients has been key as the practice continues to provide evidence-based care for cancer patients during a global pandemic.

“We’ve had to implement practice-wide changes in response to COVID-19. To make this transition as smooth as possible under these unprecedented circumstances, adaptability is key,” Dr. Wilfong said.

Some of the changes include patient screening processes, on-site safety reminders and signage, face covering protocols, enhanced telemedicine, and more.

Texas Oncology sees more than 55,000 patients in a year, and telemedicine has played an important role in safely providing high-quality cancer care to their patients from the comfort and safety of their home, when appropriate.

“Cancer patients need a large support system and we’re using these appointments to ensure our patients are staying connected to us,” Dr. Wilfong said.

For the full conversations, check out the videos below.

How I Practice Now: Practice-Wide Changes at Texas Oncology

Journal of Clinical Pathways sat down with Lalan Wilfong, M.D., vice president of quality programs and value-based care, Texas Oncology, to highlight the unique, practice-wide changes made across the network as a result of COVID-19. Dr. Wilfong explains the recent changes that Texas Oncology recently implemented keep both patients and staff safe, while continuing to provide vital care for cancer patients during the COVID-19 health crisis.

How I Practice Now: Reopening of In-Person Care at Texas Oncology?

Journal of Clinical Pathways spoke with Lalan Wilfong, M.D., vice president of quality programs and value-based care, Texas Oncology, on whether the reopening of society will correlate with the reopening of surgical cancer care at Texas Oncology as well as the reliability of mass and rapid testing. Dr. Wilfong explains that clinicians must focus on what type of care is most important and vital, and if the delay of that care will impact the patient’s health and outcomes.


For upcoming webinars visit www.TexasOncologyFoundation.org.